Insider Trading Activity Rosetta Genomics Ltd. (NASDAQ:ROSG) – Major Shareholder Bought 119,761 shares of Stock

Insider Trading Activity For Rosetta Genomics Ltd. (NASDAQ:ROSG)

Story continues below

Healthcare Master Fund Sabby , Major Shareholder of Rosetta Genomics Ltd. (NASDAQ:ROSG) reportedly Bought 119,761 shares of the company’s stock at an average price of 0.42 for a total transaction amount of $50,299.62 SEC Form

Insider Trading History For Rosetta Genomics Ltd. (NASDAQ:ROSG)

  • On 3/13/2018 Healthcare Master Fund Sabby, Major Shareholder, bought 175,828 with an average share price of $0.42 per share and the total transaction amounting to $73,847.76.
  • On 3/15/2018 Healthcare Master Fund Sabby, Major Shareholder, bought 119,761 with an average share price of $0.42 per share and the total transaction amounting to $50,299.62.
  • Analyst Ratings History For Rosetta Genomics Ltd. (NASDAQ:ROSG)

    • On 6/13/2016 Cantor Fitzgerald Reiterated Rating Buy with a price target of $0.94 to $0.82
    • On 1/6/2017 Aegis Reiterated Rating Buy with a price target of $3.50
    • On 12/18/2017 Barrington Research Downgraded rating Outperform to Market Perform

    Recent Trading Activity for Rosetta Genomics Ltd. (NASDAQ:ROSG)
    Shares of Rosetta Genomics Ltd. closed the previous trading session at 0.43 up +0.01 1.38% with 0.42010000348091125 shares trading hands.

    An ad to help with our costs